MedTrace Logo

The PIPAC-OPC7 Study: The Use of PET/CT Scans as a Method of Evaluation in Patients Treated With PIPAC, a Pilot Study.

NCT06144853 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2026-03-16

No results posted yet for this study

Summary

The pilot study will investigate the use of repeated FDG-PET/CT scans in 16 patients with peritoneal metastasis originating from abdominal cancers treated with Pressurized Intraperitoneal Aerosol Chemotherapy. The study will focus on the potential of repeated FDG-PET/CT scans to evaluate the treatment as well as the feasibility in the patient group.

Conditions

  • Peritoneal Cancer
  • Peritoneal Metastases
  • Peritoneal Carcinomatosis
  • Abdominal Cancer

Interventions

OTHER

scan

Fluorodeoxyglucose (FDG)-positron emission tomography/Computed tomography scan

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Michael B Mortensen, Professor · Odense PIPAC Center, Department of Surgery, Odense University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-15
Primary Completion
2026-03-05
Completion
2026-03-05

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06144853 on ClinicalTrials.gov